EchoIQ Limited ( ($AU:EIQ) ) has provided an announcement. Echo IQ Limited has successfully completed the clinical validation of its heart failure ...

To continue the discussion of a weak heart, congestive heart failure, it’s necessary to describe the main imaging tool used to establish the diagnosis. The echocardiogram is an elegant procedure that ...

ASX-listed Echo IQ has obtained regulatory approval in the United States for its AI-driven solution that supports structural heart disease diagnosis. Two years since coming to the US, the company has ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Coronary artery disease (CAD) is the most prevalent form of heart disease, affecting approximately 18 million adults in the ...

AI using single-lead smartwatch ECG flagged structural heart conditions with 86% sensitivity and 99% exclusion.